Inspection report spot-checks one way to kick-start GMP MRA talks, PhRMA suggests.
This article was originally published in The Tan Sheet
Executive Summary
EUROPEAN INSPECTION REPORT SPOT-CHECKS BY FDA COULD BREAK DEADLOCK between the U.S. and the European Union in developing a mutual recognition agreement (MRA), Pharmaceutical Research & Manufacturers of America Deputy VP-International Richard Saul suggested at an Oct. 30 public exchange on establishment of a Good Manufacturing Practices MRA between the U.S. and the EU.